Subscribe

GB/T 16886.1-2022 Includes Implantation In The Biological Evaluation Of Dressings. How Should Implantation Tests For Dressings Be Conducted, And How Should Sampling (e.g., Hydrocolloid Dressings) And The Implantation Site Be Selected?

2024-07-04

Select representative components and implant them using a clinical simulation approach.

Suggested Reading

How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
What factors may affect biocompatibility risk when using biological test data from similar devices for…
Do all medical devices require chemical characterization?
Why is the extraction period typically 24 hours in China for cytotoxicity testing?
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…
Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,…
How is the endotoxin limit for wound dressing products determined?

Previous: How should the evaluation of new items in the endpoint table be considered after the implementation of the new GB/T 16886.1, and what is the background of the ISO revision?